•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A06518 Summary:

BILL NOA06518
 
SAME ASNo Same As
 
SPONSORBrown K
 
COSPNSRMcDonough
 
MLTSPNSR
 
Amd §§3331 & 3337, Pub Health L
 
Requires practitioners to provide counselling to patients about the potential addictive properties of opioids prior to prescribing such medications; requires pharmacists to provide counselling to patients about the potential addictive properties of opioids at the time a prescription for opioids is filled.
Go to top

A06518 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          6518
 
                               2025-2026 Regular Sessions
 
                   IN ASSEMBLY
 
                                      March 5, 2025
                                       ___________
 
        Introduced by M. of A. K. BROWN -- read once and referred to the Commit-
          tee on Health
 
        AN  ACT to amend the public health law, in relation to requiring persons
          prescribing or dispensing opioids to counsel patients about the poten-
          tial addictive properties of opioids

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1. Section 3331 of the public health law is amended by adding
     2  a new subdivision 10 to read as follows:
     3    10. (a) Prior to prescribing any opioid to  a  patient  initiating  or
     4  being  maintained  on opioid treatment for pain, the prescribing practi-
     5  tioner shall counsel the patient and the patient's family or  caregiver,
     6  if applicable, about the potential addictive properties of opioids. Such
     7  counselling  shall  be  provided  upon  the  dispensing  of  the initial
     8  prescription and at every subsequent  visit  when  the  prescription  is
     9  renewed.
    10    (b)  The counselling required by this subdivision shall include infor-
    11  mation regarding the  risks  of  dependence,  misuse,  and  overdose,  a
    12  discussion  regarding pain management, side effects, treatment goals and
    13  the appropriate use of opioids, and the use of naloxone in case of acci-
    14  dental overdose, as well as any additional information specified by  the
    15  commissioner.
    16    (c)  The  provisions of this subdivision shall apply to online dispen-
    17  sers of controlled substances and to institutional dispensers.
    18    (d) The requirements of this subdivision shall not apply for  patients
    19  being  treated  under  any  of the following circumstances: treatment of
    20  cancer; hospice or other end-of-life care; post-surgery treatment  imme-
    21  diately  following a surgical procedure; or in a medical emergency.  For
    22  purposes of this subdivision, "medical emergency" means an acute  injury
    23  or illness that poses an immediate risk to a person's life or health.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD10222-01-5

        A. 6518                             2
 
     1    §  2. Section 3337 of the public health law is amended by adding a new
     2  subdivision 5 to read as follows:
     3    5.  (a)  Prior  to filling a prescription for any opioid for a patient
     4  initiating or being maintained on opioid treatment for pain, the pharma-
     5  cist shall counsel the patient and the patient's family or caregiver, if
     6  applicable, about the potential addictive properties  of  opioids.  Such
     7  counselling  shall  be  provided  upon  the  dispensing  of  the initial
     8  prescription and at every subsequent  visit  when  the  prescription  is
     9  renewed.
    10    (b)  The counselling required by this subdivision shall include infor-
    11  mation regarding the  risks  of  dependence,  misuse,  and  overdose,  a
    12  discussion  regarding pain management, side effects, treatment goals and
    13  the appropriate use of opioids, and the use of naloxone in case of acci-
    14  dental overdose, as well as any additional information specified by  the
    15  commissioner.
    16    (c)  The requirements of this subdivision shall not apply for patients
    17  being treated under any of the  following  circumstances:  treatment  of
    18  cancer;  hospice or other end-of-life care; post-surgery treatment imme-
    19  diately following a surgical procedure; or in a medical emergency.   For
    20  purposes  of this subdivision, "medical emergency" means an acute injury
    21  or illness that poses an immediate risk to a person's life or health.
    22    § 3. This act shall take effect on the ninetieth day  after  it  shall
    23  have become a law.
Go to top